across a wider geographical region of South America. In addition, disease progression according to the month of birth was also assessed.
MeTHoDS
This study was approved by the institutions participating in data collection. Data were gathered from four South American countries (Argentina, Brazil, Chile, and Peru) over a three-month period. A specific file containing all pertinent details of the patient's medical history was filled out by the neurologist in charge of that particular case. All patients were under the care of the physician who forwarded the data, and their diagnoses of MS were confirmed in accordance with the criteria established at the time of this diagnosis [15] [16] [17] . The data file consisted of age, gender, city of birth, date of birth, disease duration, and present disability as assessed by the expanded disability status scale (EDSS) 18 . Patients' confidentiality was maintained and no identification by name or initials was included in the database. In order to avoid duplicate cases, patients born at the same city were checked for date of birth and gender. Whenever necessary, the physicians in charge were contacted to clarify whether the patient might be the same one, receiving care from two different physicians.
A control group was also included in the study for direct comparison of month of birth, comprising males and females born at the same latitude levels and of similar ages to the patients with MS. These controls were not relatives of the patients and had similar backgrounds regarding ethnicity and socioeconomic levels. Some of the control individuals were obtained from the hospital records of non-neurological patients who did not have immune-related diseases. Other control subjects were It has been suggested that the month in which a person is born and the development of multiple sclerosis (MS) might be related through the influence of the mother' s exposure to sunlight during pregnancy, thus possibly affecting vitamin D metabolism. This theory has been supported by data from several countries in the Northern hemisphere, such as Denmark . A pooled database from Canada, the UK, Sweden, and Denmark 8 that included nearly 40,000 patients also confirmed these findings. All of these studies showed that greater numbers of individuals with MS were born at the end of the winter season in countries with high latitudes. A recent study from the USA 9 did not confirm a clear trend of seasonality for the incidence of MS. The Australian study 10 , performed with individuals in latitudes 30° to 46° South showed a tendency to higher prevalence of MS in the offspring depending only on the first trimester of pregnancy. This finding is different from that of the Northern hemisphere, where the third trimester was apparently the time where sun exposure of the mother-to-be was important. Two studies on the same subject carried out at latitudes of approximately 30° North (Israel 11 ) and 29° South (Brazil 12 ) demonstrated that the month of birth did not influence subsequent development of MS in these geographically subtropical regions, where daylight exposure does not vary so much between different seasons. To date, no study has included a wide range of latitudes, comparing the prevalence of MS according to the month of birth between regions on the same continent. Furthermore, disease progression was not shown to be influenced by the month of birth in the Netherlands 13 , while a small but long-lasting influence was observed in Canada 14 . The effects of seasonality on MS progression in South America are, as yet, unknown.
The present study aimed to assess whether the month of birth might influence the development and severity of MS data were further analyzed according to the season of birth and, again, there were no significant differences between the patients with MS and the controls (Fig 1C) . These results were confirmed with chi-square univariate analysis of the samples (p=0.8255).
As would be expected, a direct correlation existed between EDSS score and length of the disease for the whole group of patients with MS, irrespective of the latitude (p<0.0001), as assessed using Pearson's correlation test (r=0.479). This result is summarized in Fig 2A. This correlation between EDSS score and length of the disease was also observed in each of the latitude bands separately as shown in Fig 2A, that is, the longer the disease duration, the higher the EDSS (Figs 2C and D) . Using Pearson's correlation, the EDSS/disease duration was significantly correlated at latitudes 0° to 10° (p<0.007 and r=0.4518); latitudes 11° to 20° (p<0.0001 and r=0.4463); latitudes 21° to 30° (p<0.0001 and r=0.4845); and latitudes 31° to 40° (p<0.0001 and r=0.4830). There was no difference in disease progression in relation to the month or season of birth (Figs 3A-D).
DISCuSSIoN
The results from this study show that children born from pregnancies at higher latitudes in South America do not show higher incidence of MS later in life, as is the case with the seasonal pattern observed in the Northern hemisphere [1] [2] [3] [4] [5] [6] [7] [8] [9] . Therefore, it cannot be affirmed that there is a clear relationship between lower sun exposure in winter pregnancies and the development of MS later in the offspring's life in South America. Even if it is argued that the sample of this study is much smaller due to the lower prevalence of MS in South America in relation to Northern hemisphere countries, the Australian study carried out in 2010 10 also used a similar number of patients to come to their conclusions. Other factors such as mixed ethnicity in South America should not also recruited among hospital employees and individuals (nonrelatives) accompanying patients for medical or dental consultations. The MS patients and control subjects were grouped according to the latitude at which they had been born into four bands: 0° to 10° South; 11° to 20° South; 21° to 30° South; and 31° to 40° South. The month of birth of each individual (patients and controls) and the patients' clinical disability reached over a certain period of time (disease duration) were registered and analyzed separately in each of these four bands.
GraphPad Prism was used for statistical evaluation. Twoway and one-way ANOVA, chi-square analysis, linear regression analyses, Pearson' s correlation, and Student' s t-test were used to analyze the results. Significant values were those with p<0.05.
ReSuLTS
The total population samples comprised 1207 MS patients and 1207 control subjects. The patients with MS and the controls were of similar age, that is, 40.8±12.6 years old for patients and 40.6±15.5 for controls. Males and females were also similarly distributed between the patient and control groups, that is, 351 males and 856 females with MS and 396 males and 811 females as controls. A summary of the demographic data for the MS patients and controls is summarized in Table. All groups were comparable, except for the patients living at latitudes 0° to 10° South. These patients were significantly older than the other groups (p=0.008), had significantly longer disease duration (p=0.04), and had significantly higher EDSS (p=0.001) than the other patients.
The distribution of months and seasons of births of all MS patients and controls is shown in Fig 1A. There were no significant differences in the two groups when all the latitude bands (0° to 40°) were considered. Two-way ANOVA analysis on the data did not show any significant variation in MS prevalence in relation to month of birth, in any of the four Southern latitude bands evaluated, as shown in Fig 1B. The *Patients living at latitudes 0-10 o South were significantly older than the other groups (p=0.08), had significantly higher disease duration (p=0.04), and had significantly higher expanded disability scale score (EDSS) (p=0.001) than other patients. Age, disease duration, and expanded disability scale score 18 are expressed as mean value±standard deviation.
However, it can clearly be seen that the amount of sun exposure at 40° South will be substantially greater than at northern latitudes further from the Equator than the southern tip of South America (e.g., Scotland or Sweden).
It is interesting to observe that seasonality may have an influence on MS relapses, as recently described in a Brazilian city at tropical latitude 19 . The influence of sunlight, climate, and geographical characteristics of a city are indeed interesting aspects of the environment, with regard to MS development and profile, and this may differ depending on the city or country studied. However, several other factors, including genetic profile and infections, may play a more important role in MS development and severity in the countries assessed here. For example, it is possible that the age at which children start to play outdoors might influence the infections that this child acquires in early childhood. Early contact with helminths may alter the immunological system and influence the development of interfere in the month of birth, even if it can interfere in some manner in the development of MS.
Findings from the present study are likely to be explained by geographical reasons. In making comparisons between the Northern and Southern hemispheres, it has to be borne in mind that latitudes considered to be substantially southerly in South America are low in Northern hemisphere terms. The southern limit of the present study (40° South) was at the northern limit of Patagonia, a vast sparsely populated area of relatively severe climate. However, the same latitude in the Northern hemisphere (40° North) is far from being considered very northerly: it passes just north of San Francisco and Washington DC, and just south of Madrid and Rome. There is no land mass in South America equivalent to the high northerly latitudes of Europe. For example, Finland is at latitudes equivalent to the Antarctic Peninsula.
Sun exposure may be an important factor in relation to month of birth and MS at very high northern latitudes. Fig 1. (A) Month and season of birth of patients with multiple sclerosis and control subjects, irrespective of the latitude they were born in South America. There are no significant differences between patients and controls. (B) Month of birth of patients with multiple sclerosis and control subjects, grouped into four different latitude bands, showing that there were no significant differences between patients with MS and controls. Data were analyzed using two-way ANOVA and expressed as percentage numbers of births for MS patients and control subjects for each month, considering the different latitude bands: 0-10° S (p=0.7); 11-20° S (p=0.8); 21-30° S (p=0.6); and 31-40° S (p=0.5). (C) Season of birth of patients with multiple sclerosis and controls subjects, grouped into four different latitude bands (0-10°; 11-20°; 21-30°; 31-40°), showing that there were no significant differences between patients with MS and controls. Data were analyzed using two-way ANOVA. The seasons in the South American countries participating in this study were defined as follows: March to May = autumn; June to August = winter; September to November = spring; December to February = summer.
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autoimmune diseases 20 . Since exposure to helminths and other parasites may have a protective effect with regard to later development of MS 21 , the mother's exposure to sunlight during pregnancy may only be one component of the complex environmental factors associated with MS in South America. For example, it has been argued that the mother's food intake and nutritional status may affect the child's outcome in future life, including the likelihood of developing MS 22 . Gradients of MS prevalence have been observed in New Zealand 23 and Central and South America 24 . However, at least in South America, the month of birth cannot be considered to be as significant for MS prevalence as it seems to be in Northern hemisphere populations. This finding is not surprising when all the geographical considerations above mentioned are considered.
A very recent study from Dobson, Giovannoni and Ramagopalan 25 reviewed the subject of month of birth and prevalence of MS in a systematic manner. Unfortunately, the only two Southern hemisphere studies (Australian 10 and Brazilian 12 ) were considered to have (according to the authors) "data that could not be used for meta-analysis" despite the high impact factor journals they had been published. As one of the studies was performed by our group, we can also say that those authors 25 did not try to contact our group for more information or data. They concluded that in the Northern hemisphere there is a clear relationship between the month of birth and the subsequent risk of MS 25 . However, in the Southern hemisphere, the Australians have a completely different finding in relation to the time of pregnancy when the sun exposure might be relevant, while the previous Brazilian and now the South American study systematically show that the month of birth does not seem to influence the risk of MS.
Finally, and very importantly, it is essential to highlight the fact that epidemiological studies of MS in South America will never have the number of patients found in North America. Over 40 researchers from four countries added their data in order to obtain the results presented here. In some areas of South America, the prevalence of MS is as low as 1.5/100,000 24 , and many areas of the continent do not even have prevalence studies. For well-powered confirmation of the null hypothesis in the present study, tens of thousands of patients would be necessary. Other particular aspects of South American populations, such as ethnicity, were accounted for with the control groups obtained in each region of the present work. Despite these inherent limitations, the present study seems to confirm the idea that maternal exposure to sunlight may have an influence on the development of MS later in the life of an individual where sunlight exposure is indeed limited by severe winters.
In conclusion, the month or season of birth of the patients with MS in South America was not significantly different from the general population. Likewise, disease progression did not correlate with the month or season of birth of these South American patients with MS. The information from the North America and Europe once again may not be applicable to our continent, and it is imperative that our results are known rather than ignored in favor of North American and European data. 
